What are the opening hours?

Monday 9am - 6pm Tuesday 9am - 6pm Wednesday 9am - 6pm Thursday 9am - 6pm Friday 9am - 6pm

MedGenome

Home
India
Bangalore
MedGenome

MedGenome is a leading provider of molecular diagnostics solutions to hospitals and clinicians.

MedGenome is a leading provider of molecular diagnostics solutions to hospitals and clinicians, enabling personalized healthcare. Its innovative offerings in molecular diagnostics apply advanced software and bioinformatics tools to curated omics data, combined with MedGenome’s proprietary knowledge base and powerful analytics. MedGenome’s genomics bioinformatics platform is available to global pharmaceuticals, research and diagnostics organizations. MedGenome has pioneered Whole Genome, Whole Exome and Multi-Gene Panel disease panel based diagnostics in India. MedGenome genomic products and services will empower doctors and patients in matters of health and disease management by providing them with relevant genetic information. MedGenome has developed many single gene tests, disease panels and investigational tests covering Oncology, Pediatrics, Prenatal, Cardiology, Ophthalmology, Neurology, and other specialties. Our OncoMD Cancer Analytics Platform curates and validates genomics and proteomics data captured from leading peer reviewed scientific journals and other relevant data sources. The platform combines curated data with software bioinformatics and powerful analytics to deliver actionable information for clinical diagnosis and treatment decisions. MedGenome also partners with clients on genomic based exploratory research and drug discovery. Our ability to leverage existing longitudinal studies, design population studies from scratch and also conduct follow up studies on cohorts provides valuable benefits to our global research partners

MedGenome was incubated for 2 years as a division of SciGenom Labs, Cochin, India. It was spun off as a separate company with headquarters in Narayana Health City, Bangalore in 2013. MedGenome at Narayana Nethralaya (NN) has a co-located lab spanning over 10,000 sq.ft of lab space at Narayana Nethralaya. MedGenome has a multi faceted team spread across the country, facilitating its pan India operations.

27/09/2025

Featured on The Times Of India India for Gynaecological Cancer Awareness Month: https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/10-warning-signs-of-gynaecological-cancer-women-should-never-ignore/photostory/124093576.cms

Dr. Prashanth Bagali, Head of Scientific Affairs, MedGenome, highlights 10 warning signs of cancers that women should never ignore. He also emphasizes that screening and timely diagnostic workups remain critical tools in detecting conditions early when treatment is more effective.

So, listen to your body, stay aware, and don’t delay getting professional advice if you notice unusual changes.

26/09/2025

Ovarian cancer is often called the ‘silent killer’ because it is frequently detected at a late stage. Early genetic insights can help guide prevention, personalised treatment, and family risk assessment. Genetic testing also plays a critical role in identifying candidates for PARP inhibitors, which are an important treatment option, particularly for patients with certain genetic mutations such as BRCA1, BRCA2, ATM, PALB2, RAD51C, and RAD51D.

This Ovarian Cancer Awareness Month, learn how genetic testing can support better decisions, clearer outcomes, and more effective treatments.

To know more,

📨diagnostics@medgenome.com | 📞 1800 296 9696

25/09/2025

Lung cancer is often detected late, making treatment more difficult and outcomes poorer. On this World Lung Day, we highlight the importance of early and accurate testing. MedGenome’s LungTrack Advance and Lung Cancer Duo are designed to support clinicians with comprehensive profiling and sensitive mutation detection, enabling faster, personalised care for patients. Together, let’s take a step forward in the fight against lung cancer.
To know more:

📨diagnostics@medgenome.com | 📞 1800 296 9696

22/09/2025

Featured on ABP Live for

Read now: https://news.abplive.com/health/world-alzheimer-s-day-2025-alzheimer-s-symptoms-early-detection-1801483

Dr. Thenral S. Geetha, Principal Scientist at MedGenome, and Dr. Prashanth LK, Consultant Neurologist and Movement Disorders Specialist at Parkinson's Disease and Movement Disorders Clinic - Bangalore, share expert insights on Alzheimer’s Disease, the role of genetics, and management of this condition.

They emphasise how Alzheimer’s is an emotional burden as well as a medical urgency. Early awareness, genetic testing, and counselling enable informed healthcare choices, which, along with support and care, can help give better quality of life to the patients.

19/09/2025

This Thyroid Cancer Awareness Month, learn how MedGenome’s ThyroTrack can help clinicians understand thyroid nodule genetics for diagnostic accuracy and better clinical decisions. ThyroTrack screens variable genetic alterations in thyroid cancer-related genes as per ATA (2015) & NCNN (2022) guidelines.

To know more:
diagnostics@medgenome.com | 1800 296 9696

15/09/2025

DMD is a severe genetic disorder. With tools like PGT-M and PGT-A, families can identify healthy embryos early and help prevent transmission of the condition.

Check out this case study to know how genetics can play a role in supporting informed family planning!

09/09/2025

KaryoSeq uses low-pass whole genome sequencing to detect chromosomal abnormalities such as aneuploidies and copy number variations (CNVs) greater than 1 Mb. By generating genome-wide data, it supports clinicians in making accurate assessments and helps parents receive clear information for decision-making.

08/09/2025

Dr. Sakthivel Murugan, Vice President - Lab Operations, MedGenome, joined the panel of industry experts at the ET Healthcare Leaders Summit 2025 to discuss Genomics, Diagnostics, and Precision Medicine.

The conversation spanned from the evolution of preventive and proactive healthcare to technology integration, accessibility, and affordability of genetic diagnostics in India today, including key trends in genomics that are shaping the future of healthcare.

Discussing the advancements and future outlook for genomics, Dr. Murugan highlighted that a critical area of growth would be extending genomic diagnostics beyond urban centers to reach underserved rural populations, bridging the current accessibility gap. Moreover, he emphasized that a crucial shift towards reducing dependence on Western guidelines and developing India-centric guidelines for genomic testing and interpretation is the need of the hour. He said that this would recognize the unique genetic diversity and disease prevalence within the Indian population, ensuring more relevant and effective clinical applications.

On the panel, Dr. Murugan was joined by Dr. Om Manchanda, Former MD, Dr. Lal Path Labs, Dr. Harsh Mahajan, Founder & Managing Director, Mahajan Imaging, and Dr. Arjun Dang, CEO and Partner, Dr Dangs Lab. The session was moderated by Mr. Vikas Dandekar, Editor-Pharma & Healthcare, The Economic Times.

06/09/2025

We are proud and pleased to share that MedGenome has won the Excellence in Clinical Services - Genomics (National) Award at The Economic Times Healthcare Awards 2025.

At the event, Dr Sakthivel Murugan, Vice President, Lab Operations, MedGenome, received the award on our behalf.

This recognition is a testament to our commitment to advancing healthcare in India through our innovative genomic solutions and the impact we’re creating in improving patient outcomes nationwide.

We thank our dedicated team for their incredible work, our investors for their continued confidence, and our partners for their unwavering support. Your expertise, passion, and commitment to excellence are the driving force behind our success.

We also extend our gratitude to the Economic Times Healthworld so team for recognising our leadership in genomics in India.

MedGenome stands strong on the core pillars of science, technology, innovation, and quality. As we continue pushing boundaries toward broadening access to affordable genomic solutions, we look forward to achieving new milestones and moving ahead with passion and purpose.

03/09/2025

Featured on Education Times

Read the full article on: https://www.educationtimes.com/article/campus-beat-college-life/99739339/career-opportunities-in-modern-health-sciences-are-redefining-needs-of-the-healthcare-industry

Dr. Venkataswamy Eswarachari, Senior Director, Lab Operations, MedGenome, highlights that the digital revolution has transformed healthcare careers-“While traditional clinical and lab‑based roles remain essential, the healthcare ecosystem now extends far beyond the lab encompassing roles in technology, operations, marketing, and more.”

He stresses that as innovation, data‑driven approaches, and personalised medicine reshape the sector, today’s talent must span disciplines from genomics research to business, finance, and informatics to drive meaningful advancements in patient outcomes.

28/08/2025

Most people think NIPT only screens for Down Syndrome. But today’s advanced tests can also detect conditions like Edwards syndrome, Patau syndrome, s*x chromosome abnormalities, and other genetic risks, early during pregnancy. 🧬

👉 Read our blog to know what NIPT really uncovers: https://diagnostics.medgenome.com/blog/beyond-down-syndrome-modern-nipt-detection/

26/08/2025

We are delighted to share that Dr. Ravi Gupta, Vice President - Bioinformatics, MedGenome, participated in the CII Global Genomics Summit 2025 as a part of the expert panel that discussed "Building Genomics India Infrastructure – Bioinformatics, AI, Big Data, Biobanks, and Data Governance".

Sharing his insights, Dr. Ravi emphasized how bioinformatics tools are making processes more efficient, accurate, and faster today, spotlighting MedGenome's proprietary AI/ML-enabled tools that are used for the analysis of various complex diseases. He also discussed the need for standardizing genomic data in India to help future research in the field.

On the panel, Dr Ravi was joined by esteemed speakers, including Dr. Suchita Dayanand, Country Head, Illumina India, Dr. Hitesh Goswami, Cofounder and CEO, 4 Basecare, Dr Manoj Gopalkrishnan, CEO, Algorithmic Biologics, Mr. Bipin Pradeep Kumar, Co-founder, IOM Bioworks, Dr. Krishnadev Oruganty, Director - Innovations & Data Science, Bencos Research Solutions, and Vamsi Veeramachaneni, Chief Scientific Officer, Strand Life Sciences.

The event brought together thought leaders, industry experts, and policymakers for insightful conversations on advancements in the sector and optimizing the transformative power of genomic science. We extend our gratitude to Namita Kapoor Bahl and the CII team for organizing such an impactful event and inviting MedGenome to be part of it.

At MedGenome, we believe genomics holds immense potential to not just revolutionize healthcare but also strengthen India's innovation ecosystem and drive economic growth. As we work toward making genomics accessible for all, we look forward to more such collaborative events that fuel dialogue, partnerships, and progress.

Address

MedGenome Labs Ltd. Ground Floor, Tower 1, E-City Software Park, Electronic City – Phase 1
Bangalore
560100

Opening Hours

Monday	9am - 6pm
Tuesday	9am - 6pm
Wednesday	9am - 6pm
Thursday	9am - 6pm
Friday	9am - 6pm

Telephone

+9118001033691

Website

http://www.medgenome.com/

Alerts

Be the first to know and let us send you an email when MedGenome posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MedGenome:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Bangalore?